Skip to main content

VitalHub Announces Updated Date for Fourth Quarter and Annual 2025 Results

TORONTO, March 12, 2026 (GLOBE NEWSWIRE) — Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that it has updated the date for the release of its financial results for the fourth quarter and year ended December 31, 2025. The Company now expects to release its financial results on Wednesday, March 18, 2026, after market close. VitalHub will host a conference call to discuss the results on Thursday, March 19 at 8:00am EST. The change in timing reflects the need for additional time to finalize the Company’s annual financial statements. To register for the conference call please visit: https://us06web.zoom.us/webinar/register/WN_k8_Av320RimXFXW0CFzQEA About VitalHub VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive...

Continue reading

Surgery Partners, Inc. Names Lloyd Dean to Board of Directors

BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors. Mr. Dean is the former Chief Executive Officer of CommonSpirit Health, one of the largest nonprofit health systems in the United States, with 142 hospitals, over 1,000 care sites, 25,000 physicians, and 150,000 employees across 21 states. From 2019 to 2022, he led the formation and integration of CommonSpirit, advancing clinical quality, operational performance, and community health initiatives at national scale. Prior to CommonSpirit, Mr. Dean served as President and CEO of Dignity Health, where he strengthened patient experience, expanded partnerships, and elevated the organization’s leadership...

Continue reading

Navigator Gas Announces Availability of its Annual Report on Form 20-F for the Year Ended December 31, 2025

LONDON, March 12, 2026 (GLOBE NEWSWIRE) — Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces that it has filed its Annual Report on Form 20-F for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission. Form 20-F can be downloaded using the link below and is available on our website (www.navigatorgas.com) in the ‘Investors Centre’ section under ‘Financials’ then ‘SEC Filings’. Shareholders may request a hard copy at no cost using the contact details listed below. 2025 Form 20-F Annual Report About Navigator Gas Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) is the owner and operator of the world’s largest fleet of handysize liquefied...

Continue reading

Conifex Provides Corporate Update

VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”) (TSX: CFF) announced today that it has revised the time that it plans to release its fourth quarter 2025 results to before market open on March 23, 2026. Consequently, Conifex has rescheduled its fourth quarter earnings call to 8:00 AM Pacific time / 11:00 AM Eastern time on March 23, 2026, to discuss its financial results. To participate in the call, please dial the following number: Toll-Free Access (Canada/US): 1-877-883-0383Access ID: 4333506 A transcript of the call will be available upon request at investorrelations@conifex.com. For further information, please contact: Trevor PrudenChief Financial Officer(604) 216-2949 About Conifex Timber Inc. Conifex and its subsidiaries’ primary business currently includes timber harvesting,...

Continue reading

Westport to Issue Q4 2025 and Full Year 2025 Financial Results on March 26, 2026

VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (TSX: WPRT / Nasdaq: WPRT) (“Westport” or “The Company”) announces that the Company will release 2025 financial results on Thursday, March 26, 2026, after market close. A conference call and webcast to discuss the financial results and other corporate developments will be held on Friday, March 27, 2026. Time: 9:00 a.m. ET (6:00 a.m. PT)Call Link:   https://register-conf.media-server.com/register/BIe85f76e1734944a1a55b770ad7d41fe1Webcast:   https://investors.westport.com Participants may register up to 60 minutes before the event by clicking on the call link and completing the online registration form. Upon registration, the user will receive dial-in info and a unique PIN, along with an email confirming the details. The webcast will be archived...

Continue reading

BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

MISSISSAUGA, Ontario, March 12, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, March 19, 2026 after market hours. A presentation on the Company’s fourth quarter and full year 2025 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release. About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty healthcare company focused on acquiring or in-licensing, marketing and distributing innovative pharmaceutical and oral health products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives...

Continue reading

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA to patients, approximately 2,500 patients have initiated treatment with TONMYA, and cumulative prescriptions totaled approximately 4,200 Expect to initiate U.S. field study in 2027 for TNX-4800 for seasonal prevention of Lyme disease pending FDA clearance Completed $20.0 million registered direct offering with Point72 on December 29, 2025 Approximately $207.6 million in cash and cash equivalents as of December 31, 2025 BERKELEY HEIGHTS, N.J., March 12, 2026 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology company,...

Continue reading

Swiss Water Reports Year End and Fourth Quarter 2025 Results

VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (TSX:SWP) (“Swiss Water” or “the Company”), a leading specialty coffee company and premium chemical-free coffee decaffeinator, today reported financial results for the three months and fiscal year ended December 31, 2025. All amounts are expressed in Canadian dollars unless otherwise stated. Fourth Quarter 2025 HighlightsQ4’25 processed volumes decreased 2% compared to Q4’24; Revenue of $66.0 million, an increase of 34% over Q4’24; Net income of $1.2 million, a decrease of $0.8 million compared to Q4’24; Adjusted EBITDA of $4.2 million, a decrease of $0.7 million or 14% compared to Q4’24; The NY’C’ coffee futures price for Arabica coffee remained volatile during Q4’25, peaking at US$4.23/lb in November. During Q4’25, the NY’C’...

Continue reading

Cavvy Announces Warrant Exercise

Not For Distribution to United States News Wire Services or Dissemination in United States CALGARY, Alberta, March 12, 2026 (GLOBE NEWSWIRE) — Cavvy Energy Ltd. (“Cavvy” or the “Company”) (TSX:CVVY) announces the exercise of common share purchase warrants (the “Warrants”) by 2652862 Alberta Ltd., an affiliate of Erikson National Energy Inc. (“Erikson”). Proceeds will be used to repay debt. The Warrants were issued to Erikson in 2019 in connection with a debt financing to Cavvy, then Pieridae Energy Limited. The Warrants have been exercised at a price of $0.6836 per share, for proceeds of $3.5 million in exchange for the issuance of 5,120,235 common shares. The Company has 295,975,505 common shares outstanding, following the exercise of the Warrants. ABOUT CAVVY ENERGY        Cavvy Energy is an integrated Canadian upstream and midstream...

Continue reading

Phoenix Energy Announces Q4 2025 and Full-Year 2025 Earnings Call

IRVINE, Calif., March 12, 2026 (GLOBE NEWSWIRE) — Phoenix Energy One, LLC, (“Phoenix Energy” or the “Company”), an energy company (NYSE American: PHXE.P) focused on oil and gas exploration and production across key U.S. basins, with a primary footprint in the Williston Basin in North Dakota and Montana, will hold a public earnings call on Wednesday, March 18, 2026 at 1:30 PM PST to review Q4 2025 and full-year 2025 operating and financial results from its annual report on Form 10-K for the fiscal year ended December 31, 2025. Curtis Allen, Chief Financial Officer, will present an overview of the Company’s oil and gas portfolio, along with a detailed review of the financial performance and more noteworthy accomplishments of the fourth quarter and fiscal year 2025. Date: Wednesday, March 18, 2026 Time: 1:30 PM PST / 4:30 PM EST Join...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.